(-)-alpha-phellandrene increases expression ISO MAP2K6 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MAP2K6 mRNA CTD PMID:25075043 (-)-epigallocatechin 3-gallate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 o and p'-DDT promotes the reaction [MAP2K6 protein results in increased activity of CREBBP protein] CTD PMID:22609851 1,2-dimethylhydrazine decreases expression ISO Map2k6 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAP2K6 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:15834898 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP2K6 mRNA CTD PMID:26865667 17beta-estradiol multiple interactions ISO Map2k6 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of MAP2K6 mRNA] CTD PMID:25210133 17beta-estradiol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP2K6 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 and PMID:30165855 17beta-estradiol decreases expression ISO Map2k6 (Mus musculus) 6480464 Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map2k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP2K6 mRNA CTD PMID:14708085 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO MAP2K6 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map2k6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:21570461 and PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA CTD PMID:21215274 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA] CTD PMID:21215274 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO MAP2K6 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-nitrofluorene decreases expression EXP 6480464 2-nitrofluorene results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Map2k6 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO Map2k6 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP2K6 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation ISO Map2k6 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of MAP2K6 promoter CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression ISO Map2k6 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MAP2K6 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 4-hydroxyphenyl retinamide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Fenretinide results in increased phosphorylation of MAP2K6 protein CTD PMID:16407847 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 afimoxifene decreases response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MAP2K6 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases methylation ISO MAP2K6 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of MAP2K6 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 all-trans-retinoic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP2K6 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO MAP2K6 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP2K6 mRNA CTD PMID:33167477 alpha-phellandrene increases expression ISO MAP2K6 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MAP2K6 mRNA CTD PMID:25075043 amino acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Amino Acids CTD PMID:27278863 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP2K6 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MAP2K6 mRNA CTD PMID:30779732 andrographolide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein] CTD PMID:24814888 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [[MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 antirheumatic drug increases expression ISO MAP2K6 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP2K6 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP2K6 mRNA CTD PMID:33212167 arsane affects methylation ISO MAP2K6 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 arsane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 arsenic atom affects methylation ISO MAP2K6 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 arsenic atom decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 arsenite(3-) increases expression ISO Map2k6 (Mus musculus) 6480464 arsenite results in increased expression of MAP2K6 mRNA CTD PMID:18191166 arsenous acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 arsenous acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 arsenous acid multiple interactions ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 arsenous acid affects response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 atazanavir sulfate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 atazanavir sulfate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MAP2K6 gene CTD PMID:28931070 azathioprine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Azathioprine results in decreased expression of MAP2K6 mRNA CTD PMID:22623647 benzene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Benzene results in decreased expression of MAP2K6 mRNA CTD PMID:33064461 benzene increases expression ISO Map2k6 (Mus musculus) 6480464 Benzene results in increased expression of MAP2K6 mRNA CTD PMID:34624356 benzo[a]pyrene decreases expression ISO Map2k6 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:19770486 and PMID:21569818 benzo[a]pyrene decreases methylation ISO Map2k6 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of MAP2K6 intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects expression ISO MAP2K6 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of MAP2K6 mRNA CTD PMID:21714911 beta-D-glucan decreases expression ISO MAP2K6 (Homo sapiens) 6480464 beta-Glucans results in decreased expression of MAP2K6 mRNA CTD PMID:25970150 bis(2-chloroethyl) sulfide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of MAP2K6 protein CTD PMID:15251176 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of MAP2K6 mRNA CTD PMID:15651846 bis(2-ethylhexyl) phthalate decreases expression ISO Map2k6 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions ISO Map2k6 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA] CTD PMID:19850644 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP2K6 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAP2K6 gene CTD PMID:31601247 bortezomib decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Bortezomib results in decreased expression of MAP2K6 mRNA CTD PMID:20977926 bromoacetate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 bromoacetate results in decreased expression of MAP2K6 mRNA CTD PMID:19753638 cadmium dichloride multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA and Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:12634122 and PMID:18703135 cadmium dichloride increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP2K6 mRNA CTD PMID:32512071 cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18021293 and PMID:18703135 cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 cadmium dichloride increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18703135 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of MAP2K6 gene CTD PMID:30521419 carbamazepine affects expression ISO MAP2K6 (Homo sapiens) 6480464 Carbamazepine affects the expression of MAP2K6 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO Map2k6 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of MAP2K6 mRNA CTD PMID:25554681 and PMID:25620056 CGP 52608 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP2K6 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 cisplatin affects response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cisplatin results in increased expression of MAP2K6 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of MAP2K6 mRNA] and jinfukang promotes the reaction [Cisplatin results in increased expression of MAP2K6 mRNA] CTD PMID:27392435 cisplatin multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP2K6 mRNA CTD PMID:23558232 cisplatin decreases response to substance EXP 6480464 MAP2K6 protein results in decreased susceptibility to Cisplatin CTD PMID:19578154 copper atom multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP2K6 mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP2K6 mRNA more ... CTD PMID:20971185 more ... copper(II) sulfate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of MAP2K6 mRNA CTD PMID:19549813 corn oil affects expression EXP 6480464 Corn Oil affects the expression of MAP2K6 mRNA CTD PMID:16360708 crocidolite asbestos decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of MAP2K6 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 cyclosporin A increases expression ISO MAP2K6 (Homo sapiens) 6480464 Cyclosporine results in increased expression of MAP2K6 mRNA CTD PMID:27989131 D-glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 DDT multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein promotes the reaction [DDT results in increased activity of NOTCH1 protein] CTD PMID:18791200 deoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 deoxynivalenol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] CTD PMID:20181660 deoxynivalenol increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 deoxynivalenol results in increased phosphorylation of MAP2K6 protein CTD PMID:20181660 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MAP2K6 mRNA CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 diarsenic trioxide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 diarsenic trioxide multiple interactions ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 diarsenic trioxide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 diarsenic trioxide affects response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 dibenz[a,h]anthracene increases expression ISO Map2k6 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO Map2k6 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:28962523 dichromium trioxide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 diclofenac affects expression ISO MAP2K6 (Homo sapiens) 6480464 Diclofenac affects the expression of MAP2K6 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO MAP2K6 (Homo sapiens) 6480464 dicrotophos results in decreased expression of MAP2K6 mRNA CTD PMID:28302478 Didecyldimethylammonium decreases expression ISO MAP2K6 (Homo sapiens) 6480464 didecyldimethylammonium results in decreased expression of MAP2K6 mRNA CTD PMID:32763356 disodium selenite decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of MAP2K6 mRNA CTD PMID:16705456 disodium selenite increases expression ISO MAP2K6 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of MAP2K6 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MAP2K6 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects activity ISO MAP2K6 (Homo sapiens) 6480464 Doxorubicin affects the activity of MAP2K6 protein CTD PMID:15870702 doxorubicin affects methylation EXP 6480464 Doxorubicin affects the methylation of MAP2K6 gene CTD PMID:28962528 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP2K6 mRNA CTD PMID:29391264 entinostat decreases expression ISO MAP2K6 (Homo sapiens) 6480464 entinostat results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 epoxiconazole decreases expression ISO Map2k6 (Mus musculus) 6480464 epoxiconazole results in decreased expression of MAP2K6 mRNA CTD PMID:35436446 ethanol affects expression ISO Map2k6 (Mus musculus) 6480464 Ethanol affects the expression of MAP2K6 mRNA CTD PMID:30319688 filipin III multiple interactions EXP 6480464 Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 folic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Folic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:21867686 FR900359 increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of MAP2K6 protein CTD PMID:37730182 fulvestrant multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAP2K6 gene and MAP2K6 promotes the reaction [Fulvestrant results in decreased expression of GJA1 protein] CTD PMID:29180066 and PMID:31601247 gemcitabine increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 Gemcitabine results in increased phosphorylation of MAP2K6 protein CTD PMID:15003513 genistein decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Genistein results in decreased expression of MAP2K6 mRNA CTD PMID:26865667 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP2K6 mRNA CTD PMID:33387578 glucose multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 glycochenodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycocholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycodeoxycholic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:32152650 and PMID:33819548 glyphosate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Glyphosate results in decreased expression of MAP2K6 mRNA CTD PMID:31295307 hydrogen peroxide affects expression ISO MAP2K6 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of MAP2K6 mRNA CTD PMID:20044591 iron atom multiple interactions EXP 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 iron atom increases phosphorylation EXP 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 iron dichloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of MAP2K6 mRNA CTD PMID:35984750 iron(0) multiple interactions EXP 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 iron(0) increases phosphorylation EXP 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) multiple interactions EXP 6480464 ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein] more ... CTD PMID:17172471 iron(2+) sulfate (anhydrous) increases phosphorylation EXP 6480464 ferrous sulfate results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 L-ascorbic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 lead diacetate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 lipopolysaccharide multiple interactions ISO Map2k6 (Mus musculus) 6480464 IRAK2 protein promotes the reaction [Lipopolysaccharides results in increased activity of MAP2K6 protein] CTD PMID:21291324 lipopolysaccharide increases activity ISO Map2k6 (Mus musculus) 6480464 Lipopolysaccharides results in increased activity of MAP2K6 protein CTD PMID:21291324 lycopene decreases expression ISO MAP2K6 (Homo sapiens) 6480464 lycopene results in decreased expression of MAP2K6 protein CTD PMID:17337101 maneb multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 melatonin multiple interactions ISO Map2k6 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA] CTD PMID:23963992 mercury dibromide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 mercury dichloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 methotrexate affects response to substance ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methotrexate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Methotrexate results in decreased expression of MAP2K6 mRNA CTD PMID:19100307 methylmercury chloride decreases expression ISO MAP2K6 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 and PMID:28001369 mevinphos increases phosphorylation EXP 6480464 Mevinphos results in increased phosphorylation of MAP2K6 protein CTD PMID:23157661 mono(2-ethylhexyl) phthalate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:36695872 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAP2K6 gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein] CTD PMID:28939911 N-methyl-4-phenylpyridinium increases phosphorylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein CTD PMID:28939911 nefazodone multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of MAP2K6 mRNA CTD PMID:32152650 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAP2K6 mRNA CTD PMID:22110744 nickel dichloride increases response to substance ISO Map2k6 (Mus musculus) 6480464 MAP2K6 protein results in increased susceptibility to nickel chloride CTD PMID:21544193 nickel dichloride multiple interactions ISO Map2k6 (Mus musculus) 6480464 [incomplete Freund's adjuvant co-treated with Freund's Adjuvant co-treated with nickel chloride] results in increased expression of MAP2K6 mRNA more ... CTD PMID:21544193 and PMID:23536762 nicotine increases expression EXP 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 Nonylphenol increases expression ISO MAP2K6 (Homo sapiens) 6480464 nonylphenol results in increased expression of MAP2K6 protein CTD PMID:24039973 obeticholic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of MAP2K6 mRNA CTD PMID:27939613 organoselenium compound multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA CTD PMID:25167922 ouabain increases expression ISO MAP2K6 (Homo sapiens) 6480464 Ouabain results in increased expression of MAP2K6 mRNA CTD PMID:28795476 ozone multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP2K6 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAP2K6 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 p-menthan-3-ol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Menthol results in decreased expression of MAP2K6 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 paracetamol affects expression ISO Map2k6 (Mus musculus) 6480464 Acetaminophen affects the expression of MAP2K6 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAP2K6 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 paracetamol decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of MAP2K6 mRNA CTD PMID:29067470 paraquat multiple interactions ISO Map2k6 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of MAP2K6 mRNA CTD PMID:32680482 parathion increases expression ISO Map2k6 (Mus musculus) 6480464 Parathion results in increased expression of MAP2K6 mRNA CTD PMID:34813904 perfluorohexanesulfonic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of MAP2K6 mRNA CTD PMID:37995155 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of MAP2K6 gene CTD PMID:33148267 phenobarbital increases expression ISO Map2k6 (Mus musculus) 6480464 Phenobarbital results in increased expression of MAP2K6 mRNA CTD PMID:19270015 phenobarbital affects expression ISO Map2k6 (Mus musculus) 6480464 Phenobarbital affects the expression of MAP2K6 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 phlorizin increases expression ISO Map2k6 (Mus musculus) 6480464 Phlorhizin results in increased expression of MAP2K6 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate more ... CTD PMID:27278863 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 pirinixic acid multiple interactions ISO Map2k6 (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO Map2k6 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 and PMID:23811191 potassium chromate multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO MAP2K6 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 progesterone multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 progesterone increases expression ISO MAP2K6 (Homo sapiens) 6480464 Progesterone results in increased expression of MAP2K6 mRNA CTD PMID:17404688 Ptaquiloside decreases expression ISO MAP2K6 (Homo sapiens) 6480464 ptaquiloside results in decreased expression of MAP2K6 mRNA CTD PMID:22143989 quercetin increases expression ISO MAP2K6 (Homo sapiens) 6480464 Quercetin results in increased expression of MAP2K6 mRNA CTD PMID:27514524 quercetin decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Quercetin results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 MAP2K6 protein promotes the reaction [Raloxifene Hydrochloride results in increased expression of HMOX1 protein] CTD PMID:20888885 ritodrine increases expression ISO Map2k6 (Mus musculus) 6480464 Ritodrine results in increased expression of MAP2K6 mRNA CTD PMID:23370008 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAP2K6 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of MAP2K6 mRNA CTD PMID:33725128 Salinomycin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA] and [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] CTD PMID:15767673 SB 203580 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [[MAP2K6 gene mutant form results in increased activity of MAP2K6 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 SB 431542 multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Securinine decreases expression ISO MAP2K6 (Homo sapiens) 6480464 securinine results in decreased expression of MAP2K6 mRNA CTD PMID:32662633 sevoflurane increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 sevoflurane results in increased phosphorylation of MAP2K6 protein CTD PMID:18349187 silicon dioxide decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of MAP2K6 mRNA and Silicon Dioxide results in decreased expression of MAP2K6 mRNA CTD PMID:22300531 and PMID:25895662 sodium arsenite multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:12634122 and PMID:9442025 sodium arsenite increases expression ISO MAP2K6 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP2K6 mRNA CTD PMID:17879257 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MAP2K6 mRNA CTD PMID:22110744 Soman decreases expression EXP 6480464 Soman results in decreased expression of MAP2K6 mRNA CTD PMID:19281266 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of MAP2K6 mRNA CTD PMID:25905778 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of MAP2K6 mRNA CTD PMID:30047161 sulfates multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Soot co-treated with Sulfates] affects the methylation of MAP2K6 promoter CTD PMID:25395096 sulforaphane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 sulforaphane results in decreased expression of MAP2K6 mRNA CTD PMID:26833863 and PMID:31838189 Sunset Yellow FCF multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of MAP2K6 mRNA CTD PMID:33819548 tanespimycin multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA] and [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 tartrazine multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 tert-butyl hydroperoxide increases phosphorylation ISO MAP2K6 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein CTD PMID:17003459 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 tetrachloromethane decreases expression ISO Map2k6 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of MAP2K6 mRNA CTD PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MAP2K6 mRNA CTD PMID:23411599 and PMID:34492290 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:23558232 trichostatin A multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO MAP2K6 (Homo sapiens) 6480464 trichostatin A results in decreased expression of MAP2K6 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A increases expression ISO MAP2K6 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:24935251 trichostatin A multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 triclosan multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of MAP2K6 mRNA CTD PMID:33819548 trimethyltin decreases expression ISO Map2k6 (Mus musculus) 6480464 trimethyltin results in decreased expression of MAP2K6 mRNA CTD PMID:21435392 Triptolide decreases expression ISO Map2k6 (Mus musculus) 6480464 triptolide results in decreased expression of MAP2K6 mRNA CTD PMID:32835833 tris(2-butoxyethyl) phosphate affects expression ISO MAP2K6 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of MAP2K6 mRNA CTD PMID:29024780 troglitazone decreases expression ISO MAP2K6 (Homo sapiens) 6480464 troglitazone results in decreased expression of MAP2K6 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO Map2k6 (Mus musculus) 6480464 trovafloxacin results in decreased expression of MAP2K6 mRNA CTD PMID:35537566 urethane decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Urethane results in decreased expression of MAP2K6 mRNA CTD PMID:28818685 valproic acid increases expression ISO MAP2K6 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP2K6 mRNA CTD PMID:24935251 and PMID:29154799 valproic acid multiple interactions ISO MAP2K6 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 valproic acid decreases expression ISO MAP2K6 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:23179753 more ... vanadium atom increases expression ISO MAP2K6 (Homo sapiens) 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO MAP2K6 (Homo sapiens) 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753